SurModics Inc. (SRDX) Sets New 52-Week High at $29.08
SurModics Inc. (NASDAQ:SRDX) shares reached a new 52-week high during trading on Monday . The stock traded as high as $29.08 and last traded at $29.04, with a volume of 44,567 shares traded. The stock had previously closed at $28.25.
A number of brokerages have issued reports on SRDX. Zacks Investment Research lowered shares of SurModics from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. TheStreet upgraded shares of SurModics from a “hold” rating to a “buy” rating in a research note on Tuesday, April 26th. Finally, Barrington Research upped their price target on shares of SurModics from $27.00 to $30.00 and gave the company an “outperform” rating in a research note on Tuesday, May 3rd.
The stock’s 50-day moving average price is $25.67 and its 200 day moving average price is $21.85. The company has a market cap of $379.09 million and a price-to-earnings ratio of 43.44.
SurModics (NASDAQ:SRDX) last issued its earnings results on Thursday, July 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.12 by $0.25. The company had revenue of $19.97 million for the quarter, compared to analysts’ expectations of $16.31 million. During the same quarter in the previous year, the firm posted $0.30 earnings per share. SurModics’s revenue for the quarter was up 25.6% on a year-over-year basis. Equities research analysts expect that SurModics Inc. will post $1.04 earnings per share for the current fiscal year.
In related news, SVP Bryan K. Phillips sold 1,816 shares of the business’s stock in a transaction dated Tuesday, June 14th. The shares were sold at an average price of $23.44, for a total value of $42,567.04. Following the sale, the senior vice president now directly owns 25,350 shares in the company, valued at approximately $594,204. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Charles W. Olson sold 12,500 shares of the business’s stock in a transaction dated Monday, August 1st. The stock was sold at an average price of $27.08, for a total transaction of $338,500.00. Following the completion of the sale, the vice president now owns 35,531 shares in the company, valued at $962,179.48. The disclosure for this sale can be found here.
A hedge fund recently raised its stake in SurModics stock. Dimensional Fund Advisors LP boosted its position in shares of SurModics Inc. (NASDAQ:SRDX) by 0.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 515,134 shares of the company’s stock after buying an additional 1,970 shares during the period. Dimensional Fund Advisors LP owned approximately 3.96% of SurModics worth $10,442,000 as of its most recent filing with the SEC.
SurModics, Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.